Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Dec 31, 2012 · 10-K · 92 days after period end · 0001062993-12-005603
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Net Income | -$674.23K | -$1.87M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Dec 31, 2012 · 92 d after period end
